Respiree
PrivateLast Round
Series A
Extension
Sep 22, 2026
Total Funding Raised
$15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Respiree operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A Extension round in September 2026.
Respiree is a health technology company that provides an AI-powered platform and proprietary sensors for monitoring and managing cardio-respiratory health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Respiree Comparables
Compare Respiree with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioIntelliSense | 87% | |
| Biobeat | 84% | |
| Aevice Health | 84% |
For institutional investors. Book with your work email.
Respiree Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 22, 2026 | ||||
| Series A | Jul 23, 2025 | ||||
| Seed | Mar 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Respiree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A Extension, Series A, Seed |
| One Six 8 Ventures | Series A Extension |
| We Venture Capital | Series A Extension, Series A |
| Bizedge Capital | Series A Extension |
| ClavystBio | Series A Extension, Series A |
| Greenwillow Capital Management | Convertible Debt, Series A Extension, Series A, Seed |
| she1K | Series A Extension, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Led by ClavystBio and We Venture Capital.
- Jul 23, 2025
$12M round completed.
For institutional investors. Book with your work email.
Respiree Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Respiree's valuation, stock price, and market status.
Is Respiree a public or private company?
Respiree is a private company.
What is the current stock price of Respiree?
Respiree is a private company, so its shares have no public market price. Caplight tracks Respiree's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Respiree worth (valuation)?
Valuation information for Respiree is not publicly available.
Can I buy Respiree stock?
Respiree shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Respiree's last funding round?
Respiree's most recent funding round was Series A Extension on September 22, 2026.
Who are the main investors in Respiree?
Key investors in Respiree include SEEDS Capital, We Venture Capital, ClavystBio, Greenwillow Capital Management, she1K.
Will Respiree IPO soon?
No public IPO plans have been announced for Respiree.
How can I track Respiree secondary market activity?
Caplight tracks bids, offers, and trades in Respiree's shares on secondary markets.